Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP
ERCP
Effectivity of Benzydamine Hydrochloride Gargle to Reduce Propofol Consumption in Endoscopic Retrograde Cholangiopancreatography Procedure
1 other identifier
interventional
72
1 country
1
Brief Summary
It was a study aimed to determine the effectivity of benzydamine hydrochloride gargling in reducing propofol consumption in the Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2018
CompletedFirst Submitted
Initial submission to the registry
November 8, 2019
CompletedFirst Posted
Study publicly available on registry
November 19, 2019
CompletedNovember 19, 2019
November 1, 2019
1 month
November 8, 2019
November 15, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Cumulative Propofol Consumption
About 1 mg/kg Propofol was initially administered to sedate the subjects. If the subject's RSS (Ramsay Sedation Scale) rose, 0.3 mg/kg was additionally given. The amount of propofol used, as in mg/kg, during the ERCP procedure was recorded.
90 minutes
Incidence of Sore Throat
Sore throat incidence after ERCP procedure was recorded
4 hours
Study Arms (2)
Benzydamine Hydrochloride Group
ACTIVE COMPARATORSubjects who were allocated in benzydamine group would gargle with 15 of ml benzydamine hydrochloride 0.15% before sedation started.
Control Group
PLACEBO COMPARATORSubjects who were allocated in control group would gargle with 15 ml of water before sedation started.
Interventions
Benzydamine Hydrochloride 0.15% Oral Rinse was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.
Water was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.
Eligibility Criteria
You may qualify if:
- undergoing ERCP
- ASA I-III
- BMI 18-30 kg/m2
You may not qualify if:
- allergic to propofol
- contraindicated to propofol
- had throat wound or laceration
- received analgesics or steroid in 24 hours priorly
- unstable during sedation
- procedure longer than 90 minutes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cipto Mangunkusumo General Hospital
Jakarta Pusat, DKI Jakarta, 10430, Indonesia
Related Publications (4)
Triantafillidis JK, Merikas E, Nikolakis D, Papalois AE. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol. 2013 Jan 28;19(4):463-81. doi: 10.3748/wjg.v19.i4.463.
PMID: 23382625BACKGROUNDYang JF, Farooq P, Zwilling K, Patel D, Siddiqui AA. Efficacy and Safety of Propofol-Mediated Sedation for Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP). Dig Dis Sci. 2016 Jun;61(6):1686-91. doi: 10.1007/s10620-016-4043-3. Epub 2016 Jan 29.
PMID: 26825844BACKGROUNDKati I, Tekin M, Silay E, Huseyinoglu UA, Yildiz H. Does benzydamine hydrochloride applied preemptively reduce sore throat due to laryngeal mask airway? Anesth Analg. 2004 Sep;99(3):710-712. doi: 10.1213/01.ANE.0000133142.52961.8D.
PMID: 15333399BACKGROUNDSugiarto A, Kapuangan C, Tantri AR, Chrisnata V. Effectivity of benzydamine hydrochloride gargle to reduce propofol consumption in endoscopic retrograde cholangiopancreatography procedure: a randomized controlled trial. BMC Anesthesiol. 2020 May 23;20(1):123. doi: 10.1186/s12871-020-00996-x.
PMID: 32446304DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adhrie Sugiarto, MD
Indonesia University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Staff
Study Record Dates
First Submitted
November 8, 2019
First Posted
November 19, 2019
Study Start
August 1, 2018
Primary Completion
September 1, 2018
Study Completion
October 1, 2018
Last Updated
November 19, 2019
Record last verified: 2019-11
Data Sharing
- IPD Sharing
- Will not share